Search Results - "Han MAT"

Macrophages-Mediated Liver Fibrosis: A Bibliometric Analysis.

Authors: Menglin Yao Ting Wang TianpengLiu et al.

Source: Hepatitis Monthly. Dec2024, Vol. 24 Issue 1, p1-12. 12p.

Non-alcoholic fatty liver disease in Northeast India: a narrative review of rising metabolic syndrome.

Authors: Longkumer, Shiludi Swargiary, Maitrayee Dutta

Source: Egyptian Liver Journal. 1/13/2026, Vol. 16 Issue 1, p1-7. 7p.

Monitoring disease progression in metabolic dysfunction‐associated steatotic liver disease.

Authors: Noureddin, Nabil Copur‐Dahi, Nedret Loomba, Rohit

Source: Alimentary Pharmacology & Therapeutics. 2024 Supplement 1, Vol. 59 Issue 1, pS41-S51. 11p.

Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice.

Authors: Camps, Gracián Maestro, Sheila Torella, Laura et al.

Source: PLoS Pathogens. 5/13/2024, Vol. 20 Issue 5, p1-21. 21p.

Machine learning models using non-invasive tests & B-mode ultrasound to predict liver-related outcomes in metabolic dysfunction-associated steatotic liver disease.

Authors: Kosick, Heather Mary-Kathleen McIntosh, Chris Bera, Chinmay et al.

Source: Scientific Reports. 7/7/2025, Vol. 15 Issue 1, p1-15. 15p.

AI‐based digital pathology provides newer insights into lifestyle intervention‐induced fibrosis regression in MASLD: An exploratory study.

Authors: Yuan, Hai‐Yang Tong, Xiao‐Fei Ren, Ya‐Yun et al.

Source: Liver International. Oct2024, Vol. 44 Issue 10, p2572-2582. 11p.

磁共振弹性成像在代谢相关脂肪性肝病肝纤维化评价中的应用.

Alternate Title: Application of magnetic resonance elastography in assessment of liver fibrosis in metabolic dysfunction-associated fatty liver disease.

Authors: 张, 子毅 尤, 红 佟, 小非

Source: Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi. Mar2026, Vol. 42 Issue 3, p683-689. 7p.

Preparation of thermal/pH‐sensitive semi‐interpenetrating network hydrogels from quaternary chitosan via an amino‐anhydride click reaction for efficient dye removal from aqueous solutions.

Authors: Zhang, Yaqi Liu, Yuhua Wei, Hongliang et al.

Source: Polymer Engineering & Science; May2023, Vol. 63 Issue 5, p1373-1387, 15p

The relationship between liver stiffness, fat content measured by liver elastography, and coronary artery disease: a study based on the NHANES database.

Authors: Li, Shengnan Li, Xiaoxue Xiao, Hua et al.

Source: Scientific Reports. 8/16/2025, Vol. 15 Issue 1, p1-19. 19p.

Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis: a randomized controlled pilot clinical trial.

Authors: Zhao, Jingjie Wang, Qianyi Zhao, Xinyu et al.

Source: Chinese Medicine. 2/24/2023, Vol. 18 Issue 1, p1-12. 12p.

Liver fibrosis is associated with left ventricular remodeling: insight into the liver-heart axis.

Authors: Edin, Carl Ekstedt, Mattias Karlsson, Markus et al.

Source: European Radiology. Nov2024, Vol. 34 Issue 11, p7492-7502. 11p.

Subjects: Hepatic fibrosis, Non-alcoholic fatty liver disease, Interleukin-1 receptors, Magnetic resonance imaging, Type 2 diabetes

Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017–2018.

Authors: Elguezabal Rodelo, Rebeca Garazi Porchia, Leonardo M. Torres‐Rasgado, Enrique et al.

Source: PLoS ONE. 2/23/2024, Vol. 19 Issue 2, p1-23. 23p.

Von Willebrand factor and factor VIII as potential biomarkers for diagnosis and disease monitoring in chronic graft-versus-host disease.

Authors: Lelas A Desnica L Sabol I et al.

Source: Bone marrow transplantation [Bone Marrow Transplant] 2026 Jul; Vol. 61 (7), pp. 883-890. Date of Electronic Publication: 2026 May 19.

Publication Type: Journal Article; Clinical Trial

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

Incidence of Cirrhosis in Fibrotic Metabolic Dysfunction-Associated Steatohepatitis: A Meta-Analysis of Placebo Arms from Randomized Clinical Trials.

Authors: Khalil SM Al-Sharif L Diaz I et al.

Source: Digestive diseases and sciences [Dig Dis Sci] 2026 Jun 18. Date of Electronic Publication: 2026 Jun 18.

Publication Type: Journal Article

Journal Info: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 7902782 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2568 (Electronic) Linking ISSN: 01632116 NLM ISO Abbreviation: Dig Dis Sci Subsets: MEDLINE

The neutrophil-to-lymphocyte ratio predicts all-cause and cardiovascular mortality in patients with nonalcoholic fatty liver disease: Evidence from the National Health and Nutrition Examination Survey 1999 to 2018.

Authors: Du Z Jiang J Lv X et al.

Source: Medicine [Medicine (Baltimore)] 2026 May 29; Vol. 105 (22), pp. e48962.

Publication Type: Journal Article

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

The diagnostic value of MRE in patients with decompensated cirrhosis: comparing it to Gd-EOB-DTPA-enhanced MRI.

Authors: Duan M Sun Z Chu Q et al.

Source: BMC medical imaging [BMC Med Imaging] 2026 May 20; Vol. 26 (1). Date of Electronic Publication: 2026 May 20.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968553 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2342 (Electronic) Linking ISSN: 14712342 NLM ISO Abbreviation: BMC Med Imaging Subsets: MEDLINE

Dietary patterns and metabolic dysfunction-associated fatty liver disease in China's multi-ethnic regions.

Authors: Zhu, Xingren Qucuo, Nima Zhang, Ning et al.

Source: Journal of Health, Population & Nutrition. 12/13/2023, Vol. 42 Issue 1, p1-10. 10p.

A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts.

Authors: Knöchel, Jane Bergenholm, Linnéa Ibrahim, Eman et al.

Source: CPT: Pharmacometrics & Systems Pharmacology. Dec2023, Vol. 12 Issue 12, p2038-2049. 12p.

MEFIB‐Index and MAST‐Score in the assessment of hepatic decompensation in metabolic dysfunction‐associated steatosis liver disease—Individual participant data meta‐analyses.

Authors: Noureddin, Nabil Ajmera, Veeral Bergstrom, Jaclyn et al.

Source: Alimentary Pharmacology & Therapeutics. Nov2023, Vol. 58 Issue 9, p856-865. 10p.

Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality.

Authors: Higuchi, Mayu Tamaki, Nobuharu Kurosaki, Masayuki et al.

Source: Alimentary Pharmacology & Therapeutics. Feb2022, Vol. 55 Issue 3, p292-301. 10p. 1 Chart, 3 Graphs.